Cargando…
Long‐term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) is a progressive muscle‐wasting disease caused by mutations in the dystrophin gene, which leads to structural instability of the dystrophin–glycoprotein‐complex with subsequent muscle degeneration. In addition, muscle inflammation has been implicated in...
Autores principales: | Zschüntzsch, Jana, Jouvenal, Pia Vanessa, Zhang, Yaxin, Klinker, Florian, Tiburcy, Malte, Liebetanz, David, Malzahn, Dörthe, Brinkmeier, Heinrich, Schmidt, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432639/ https://www.ncbi.nlm.nih.gov/pubmed/32436338 http://dx.doi.org/10.1002/jcsm.12569 |
Ejemplares similares
-
Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy
por: CARBERRY, STEVEN, et al.
Publicado: (2013) -
Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse
por: Merckx, Caroline, et al.
Publicado: (2022) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012) -
Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021) -
Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)